Steven J. Shire
Steven J. Shire publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Biomedical Engineering, on topics such as Protein purification and stability, Monoclonal and Polyclonal Antibodies Research and Viral Infectious Diseases and Gene Expression in Insects.
- World rank
- #142,497 of 7,710,434 ranked researchers
- Rank in United States
- #53,887 of 1,627,098
- Works
- 120
- Citations
- 9k
- Citations per work
- 74.9
What does Steven J. Shire research?
Steven J. Shire's work is mostly in Biochemistry, Genetics and Molecular Biology (38%), Medicine (22%), Engineering (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences5444.9%
- Everything else3226.3%
- Health Sciences2621.9%
- Medicine2621.9%
- Physical Sciences86.9%
- Engineering86.9%
- 1Molecular Biology38% of their works
- 2Radiology, Nuclear Medicine and Imaging16% of their works
- 3Biomedical Engineering7% of their works
- 4Pulmonary and Respiratory Medicine6% of their works
- 5Immunology4% of their works
- 6Plant Science3% of their works
Research topics
- Protein purification and stability
- Monoclonal and Polyclonal Antibodies Research
- Viral Infectious Diseases and Gene Expression in Insects
- Microfluidic and Capillary Electrophoresis Applications
- Protein Structure and Dynamics
- Protein Interaction Studies and Fluorescence Analysis
- Inhalation and Respiratory Drug Delivery
- Transgenic Plants and Applications
Which keywords describe Steven J. Shire's research?
The keywords of their largest research topics: Monoclonal Antibodies, Therapeutic Antibodies, Biopharmaceuticals, Recombinant Proteins, Glycosylation, Protein Aggregation, Stability and Antibody Engineering.
- Plant Molecular Farming
- Inhaler Devices
- Protein Binding
- Protein
- Lab-on-a-Chip
- Mammalian Cells
- Antibody Engineering
- Protein Aggregation
- Recombinant Proteins
- Therapeutic Antibodies
- Monoclonal Antibodies
- Biopharmaceuticals
- Glycosylation
- Stability
- Fc Receptors
- Recombinant Protein
- Poly(dimethylsiloxane)
- Structure
- Serum Albumin
- Pulmonary Drug Delivery
- Vaccine Antigens
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Monoclonal Antibodies1252 topics
- Therapeutic Antibodies1252 topics
- Biopharmaceuticals792 topics
- Recombinant Proteins792 topics
- Glycosylation742 topics
- Protein Aggregation721 topic
- Stability721 topic
- Antibody Engineering531 topic
- Fc Receptors531 topic
- Mammalian Cells211 topic
- Recombinant Protein211 topic
- Lab-on-a-Chip171 topic
- Poly(dimethylsiloxane)171 topic
- Protein101 topic
- Structure101 topic
- Protein Binding91 topic
- Serum Albumin91 topic
- Inhaler Devices81 topic
- Pulmonary Drug Delivery81 topic
- Plant Molecular Farming71 topic
- Vaccine Antigens71 topic
Where does Steven J. Shire work?
Steven J. Shire's main affiliation in the publication record is Pharmaceutical Product Development (United States), United States.
How many publications and citations does Steven J. Shire have?
OpenAlex counts 120 works and 8,986 citations for Steven J. Shire, an h-index of 45, ranking #142,497 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Steven J. Shire. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.